Aveanna Healthcare (AVAH) director Robert Williams exits board, leaves key committees

Q: What board change did Aveanna Healthcare (AVAH) disclose in this 8-K?

Aveanna Healthcare disclosed that director Robert M. Williams, Jr. resigned from the Board effective February 27, 2026. He previously served as a Class I director and sat on three key committees overseeing governance, compensation, and clinical quality and compliance.

Q: Did Robert M. Williams, Jr. resign from Aveanna Healthcare (AVAH) due to a disagreement?

No. Aveanna stated that Mr. Williams’ resignation was not the result of any disagreement with the company. This includes no disputes regarding its operations, policies, or practices, suggesting a routine governance change rather than a conflict-driven departure.

Q: What committees did Robert M. Williams, Jr. serve on at Aveanna Healthcare (AVAH)?

Before resigning, Mr. Williams served on the Nominating and Corporate Governance Committee , the Compensation Committee , and the Clinical Quality and Compliance Committee . These roles involved oversight of board composition, executive pay, and quality and compliance matters.

Q: When did the director resignation at Aveanna Healthcare (AVAH) become effective?

The resignation of Robert M. Williams, Jr. became effective immediately on February 27, 2026 . The same date appears on the company’s signed report, which is executed by Chief Executive Officer Jeff Shaner as principal executive officer.

Q: Who signed the Aveanna Healthcare (AVAH) 8-K reporting the director resignation?

The report was signed by Jeff Shaner , Aveanna Healthcare’s Chief Executive Officer and principal executive officer. His signature indicates the company’s formal authorization and certification of the disclosed board change under the Securities Exchange Act of 1934.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. reported that Robert M. Williams, Jr. has resigned from its Board of Directors effective February 27, 2026. He had served as a Class I director and was a member of the Nominating and Corporate Governance, Compensation, and Clinical Quality and Compliance Committees.

The company stated that Mr. Williams’ decision to resign was not due to any disagreement with Aveanna regarding its operations, policies, or practices. The filing is signed by Chief Executive Officer Jeff Shaner.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding 8-K Material Events →

Accepted by SEC EDGAR 02/27/2026 - 04:30 PM

FAQ

What board change did Aveanna Healthcare (AVAH) disclose in this 8-K?

Aveanna Healthcare disclosed that director Robert M. Williams, Jr. resigned from the Board effective February 27, 2026. He previously served as a Class I director and sat on three key committees overseeing governance, compensation, and clinical quality and compliance.

Did Robert M. Williams, Jr. resign from Aveanna Healthcare (AVAH) due to a disagreement?

No. Aveanna stated that Mr. Williams’ resignation was not the result of any disagreement with the company. This includes no disputes regarding its operations, policies, or practices, suggesting a routine governance change rather than a conflict-driven departure.

What committees did Robert M. Williams, Jr. serve on at Aveanna Healthcare (AVAH)?

Before resigning, Mr. Williams served on the Nominating and Corporate Governance Committee, the Compensation Committee, and the Clinical Quality and Compliance Committee. These roles involved oversight of board composition, executive pay, and quality and compliance matters.

When did the director resignation at Aveanna Healthcare (AVAH) become effective?

The resignation of Robert M. Williams, Jr. became effective immediately on February 27, 2026. The same date appears on the company’s signed report, which is executed by Chief Executive Officer Jeff Shaner as principal executive officer.

Who signed the Aveanna Healthcare (AVAH) 8-K reporting the director resignation?

The report was signed by Jeff Shaner, Aveanna Healthcare’s Chief Executive Officer and principal executive officer. His signature indicates the company’s formal authorization and certification of the disclosed board change under the Securities Exchange Act of 1934.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported): February 27, 2026

    

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

400 Interstate North Parkway SE
Atlanta, Georgia		30339
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: 770 441-1580

    

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	AVAH	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 27, 2026, Robert M. Williams, Jr. informed the Board of Directors (the “Board”) of Aveanna Healthcare Holdings Inc. (the “Company”) of his decision to resign from his position as a Class I director of the Board, effective immediately. The decision by Mr. Williams to resign from the Board was not the result of any disagreement with the Company on any matter regarding the Company’s operations, policies or practices.

Prior to his resignation, Mr. Williams served as a member of the Nominating and Corporate Governance Committee, the Compensation Committee, and the Clinical Quality and Compliance Committee.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			AVEANNA HEALTHCARE HOLDINGS INC.

Date:	February 27, 2026	By:	/s/ Jeff Shaner
			Jeff Shaner Chief Executive Officer (Principal Executive Officer)

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document